Karyopharm Therapeutics Inc (KPTI): Eigentümerstruktur
Der letzte verfügbare Schlusskurs ist 03.09.2026. Die angezeigten Informationen beziehen sich auf den historischen Stand und sind nicht tagesaktuell.
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 7,25 US Dollar | 4 | 2 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 22.681.460 | 42,72 | 4,05 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Karyopharm Therapeutics Inc
Mitarbeiter 228
Handelsplatz NASDAQ
Ticker Symbol KPTI
IPO Datum 2013-11-06
Adresse 85 Wells Avenue, Newton, MA, United States, 02459-3298
Webseite https://www.karyopharm.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Richard A. Paulson M.B.A. | President, CEO & Director |
| 2 | Mr. Stuart Poulton | Executive VP & Chief Development Officer |
| 3 | Dr. Reshma Rangwala M.D., Ph.D. | Executive VP, Chief Medical Officer & Head of Research |
| 4 | Dr. Sharon Shacham M.B.A., Ph.D. | Co-Founder & Chairman of Scientific Advisory Board |
| 5 | Ms. Lori A. Macomber CPA | EVP, CFO & Treasurer |
| 6 | Ms. Kristin Abate | VP, Chief Accounting Officer & Assistant Treasurer |
| 7 | Mr. Brendan Twohig Strong | Senior Vice President of Investor Relations |
| 8 | Mr. Michael J. Mano J.D. | Executive VP, Chief Legal Officer & Secretary |
| 9 | Mr. James Accumanno J.D. | Chief Compliance Officer |
| 10 | Ms. Lisa DiPaolo | Executive VP & Chief Human Resource Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | COMMODORE CAPITAL LP | 8,60% | 3,45 Mio. USD |
| 2 | RA Capital Management, LLC | 8,45% | 3,39 Mio. USD |
| 3 | T. Rowe Price Investment Management,Inc. | 6,80% | 2,73 Mio. USD |
| 4 | Adage Capital Partners Gp LLC | 6,71% | 2,69 Mio. USD |
| 5 | The Goldman Sachs Group Inc | 4,18% | 1,68 Mio. USD |
| 6 | Catalio Capital Management, LP | 4,15% | 1,67 Mio. USD |
| 7 | Avidity Partners Management LP | 4,08% | 1,64 Mio. USD |
| 8 | Vanguard Capital Management, LLC | 3,26% | 1,31 Mio. USD |
| 9 | Ikarian Capital, LLC | 3,23% | 1,30 Mio. USD |
| 10 | Affinity Asset Advisors, LLC | 2,20% | 0,89 Mio. USD |
| 11 | Soleus Capital Management, L.P. | 1,94% | 0,78 Mio. USD |
| 12 | Millennium Management LLC | 1,35% | 0,54 Mio. USD |
| 13 | Boxer Capital Management, LLC | 1,33% | 0,54 Mio. USD |
| 14 | Davidson Kempner Capital Management LP | 1,32% | 0,53 Mio. USD |
| 15 | Eversept Partners, LP | 1,22% | 0,49 Mio. USD |
| 16 | Jump Financial LLC | 1,16% | 0,46 Mio. USD |
| 17 | Trexquant Investment LP | 1,14% | 0,46 Mio. USD |
| 18 | Acadian Asset Management LLC | 1,10% | 0,44 Mio. USD |
| 19 | BlackRock Inc | 1,08% | 0,43 Mio. USD |
| 20 | BOOTHBAY FUND MANAGEMENT, LLC | 0,94% | 0,38 Mio. USD |